Shed syndecan-1 inhibits myeloma cell growth: A mechanism of autocrine growth control in multiple myeloma.

被引：0
|
作者：
Dhodapkar, M
Theus, A
Langford, K
Butch, A
Barlogie, B
Sanderson, R
机构：
[1] UNIV ARKANSAS,LITTLE ROCK,AR 72204
[2] VAMC,LITTLE ROCK,AR
来源：
BLOOD | 1996年 / 88卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：395 / 395
页数：1
相关论文
共 50 条
  • [41] Mechanisms of myeloma cell growth control
    Jelinek, DF
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1999, 13 (06) : 1145 - +
  • [42] Elevated levels of shed syndecan-1 correlate with tumour mass and decreased matrix metalloproteinase-9 activity in the serum of patients with multiple myeloma
    Dhodapkar, MV
    Kelly, T
    Theus, A
    Athota, AB
    Barlogie, B
    Sanderson, RD
    BRITISH JOURNAL OF HAEMATOLOGY, 1997, 99 (02) : 368 - 371
  • [43] Expression of EGF-family receptors and amphiregulin in multiple myeloma. Amphiregulin is a growth factor for myeloma cells
    Karène Mahtouk
    Dirk Hose
    Thierry Rème
    John De Vos
    Michel Jourdan
    Jérôme Moreaux
    Geneviève Fiol
    Marc Raab
    Eric Jourdan
    Véronique Grau
    Marion Moos
    Hartmut Goldschmidt
    Marion Baudard
    Jean François Rossi
    Friedrich W Cremer
    Bernard Klein
    Oncogene, 2005, 24 : 3512 - 3524
  • [44] Expression of EGF-family receptors and amphiregulin in multiple myeloma.: Amphiregulin is a growth factor for myeloma cells
    Mahtouk, K
    Hose, D
    Rème, T
    De Vos, J
    Jourdan, M
    Moreaux, J
    Fiol, G
    Raab, M
    Jourdan, E
    Grau, V
    Moos, M
    Goldschmidt, H
    Baudard, M
    Rossi, JF
    Cremer, FW
    Klein, B
    ONCOGENE, 2005, 24 (21) : 3512 - 3524
  • [45] SUPPRESSION OF TUMOR-CELL GROWTH BY SYNDECAN-1 ECTODOMAIN
    MALI, M
    ANDTFOLK, H
    MIETTINEN, HM
    JALKANEN, M
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (45) : 27795 - 27798
  • [46] Fibroblast growth factor receptor 3 as a therapeutic target in multiple myeloma.
    Paterson, JL
    Li, ZH
    Bali, M
    Trieu, Y
    Pollett, J
    Stewart, AK
    BLOOD, 2001, 98 (11) : 773A - 773A
  • [47] High levels of soluble syndecan-1 in myeloma-derived bone marrow: modulation of hepatocyte growth factor activity
    Seidel, C
    Borset, M
    Hjertner, O
    Cao, DJ
    Abildgaard, N
    Hjorth-Hansen, H
    Sanderson, RD
    Waage, A
    Sundan, A
    BLOOD, 2000, 96 (09) : 3139 - 3146
  • [48] Inhibition of the insulin like growth factor 1 receptor by a specific monoclonal antibody in multiple myeloma.
    Gualberto, A
    Alsina, M
    Lacy, M
    Poutney, S
    Birgin, A
    Littman, B
    Melvin, C
    Petersen, J
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 203S - 203S
  • [49] Syndecan-1 expression inhibits myoblast differentiation through a basic fibroblast growth factor-dependent mechanism
    Larraín, J
    Carey, DJ
    Brandan, E
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (48) : 32288 - 32296
  • [50] Platelet Factor 4 Potently Inhibits Tumor Cell Growth and Angiogenesis In Multiple Myeloma
    Liang, Pei
    Cheng, Suk-Hang
    Cheng, Chi-Keung
    Lau, Kin-Mang
    Chan, Natalie Pui Ha
    Ip, Rosalina K. L.
    Wong, Raymond S. M.
    Ng, Margaret H. L.
    BLOOD, 2010, 116 (21) : 1698 - 1698
12345